Lebwohl David (CIK 1810882) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-03). Recent activity: Buy NTLA (9,943 shares), Sell NTLA (11,903 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-03 | Intellia Therapeutics, Inc. (NTLA) | EVP, Chief Medical Officer | Buy | 9,943 | $0 |
| 2026-01-07 | Intellia Therapeutics, Inc. (NTLA) | EVP, Chief Medical Officer | Sell | 11,903 | $109,627 |
来源：SEC Form 4 申报文件 · 截至 2026-03-03